Has novelty in healthcare gone a little stale?
Date of this Version
Extract: Although drugs are essential, the roar of their marketing distorts decision making in favour of the newest and most expensive pills at the expense of older ones or of non-drug approaches. New diagnostic technologies offer undreamt of opportunities to detect ever earlier signs of illness, but they have also brought the increasingly recognised risk of overdiagnosis. Much has been written about how promotion can drive inappropriate use of valuable technologies, but does our deep love affair with novelty deserve more scrutiny?
This document has been peer reviewed.